We are live on ! Find out more
VCM

Voleon Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 56.94%
This Fund
S&P 500
This Quarter Est. Return
+31.2%
1 Year Est. Return
+56.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.49B
AUM Growth
+$849M
Cap. Flow
+$57M
Cap. Flow %
1.04%
Top 10 Hldgs %
29.1%
Holding
957
New
177
Increased
251
Reduced
333
Closed
196

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.7M
2
META icon
Meta Platforms (Facebook)
META
+$41.2M
3
MRK icon
Merck
MRK
+$26.1M
4
INTU icon
Intuit
INTU
+$24.7M
5
AZN icon
AstraZeneca
AZN
+$23.6M

Top Sells

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$29.3M
2
QCOM icon
Qualcomm
QCOM
+$28.6M
3
FTNT icon
Fortinet
FTNT
+$26.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$22.1M
5
LLY icon
Eli Lilly
LLY
+$20.8M

Sector Composition

Rank Sector Weight
1 Technology 34.25%
2 Financials 12.04%
3 Healthcare 11.39%
4 Industrials 10.72%
5 Consumer Discretionary 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
626
Aclaris Therapeutics
ACRS
$783M
$408K 0.01%
+77,168
New +$344K
KNSL icon
627
Kinsale Capital Group
KNSL
$8.2B
$408K 0.01%
1,236
+487
+65% +$157K
OLN icon
628
Olin
OLN
$1.96B
$407K 0.01%
20,551
-85,239
-81% -$2.23M
AAL icon
629
American Airlines Group
AAL
$8.61B
$407K 0.01%
22,532
-9,579
-30% -$128K
KBR icon
630
KBR
KBR
$4.61B
$405K 0.01%
11,728
+5,934
+102% +$207K
BOW
631
Bowhead Specialty Holdings
BOW
$1.11B
$397K 0.01%
13,250
-7,744
-37% -$201K
LIN icon
632
Linde
LIN
$215B
$396K 0.01%
764
-354
-32% -$179K
WOLF icon
633
Wolfspeed
WOLF
$1.35B
$394K 0.01%
+8,171
New +$356K
DINO icon
634
HF Sinclair
DINO
$19.2B
$391K 0.01%
5,617
-130
-2% -$8.64K
ETN icon
635
Eaton
ETN
$165B
$389K 0.01%
912
-8,105
-90% -$3.27M
BWAY
636
Brainsway
BWAY
$560M
$385K 0.01%
+24,811
New +$376K
BB icon
637
BlackBerry
BB
$4.5B
$374K 0.01%
+29,538
New +$206K
U icon
638
Unity
U
$19.3B
$372K 0.01%
+13,005
New +$346K
ALRM icon
639
Alarm.com
ALRM
$2.72B
$370K 0.01%
7,920
-36
-0.5% -$1.61K
NICE icon
640
Nice
NICE
$5.75B
$367K 0.01%
+4,035
New +$391K
OBT icon
641
Orange County Bancorp
OBT
$513M
$366K 0.01%
+9,964
New +$347K
DOCU
642
DocuSign
DOCU
$12.3B
$364K 0.01%
+8,196
New +$384K
CABO icon
643
Cable One
CABO
$121M
$363K 0.01%
+6,831
New +$459K
PSNL icon
644
Personalis
PSNL
$1.73B
$355K 0.01%
+26,502
New +$216K
SFIX
645
Stitch Fix
SFIX
$394M
$353K 0.01%
85,976
+62,677
+269% +$228K
GDOT icon
646
Green Dot
GDOT
$756M
$352K 0.01%
26,090
-11,842
-31% -$148K
DOX icon
647
Amdocs
DOX
$6.41B
$352K 0.01%
6,958
-11,315
-62% -$694K
JBS
648
JBS N.V.
JBS
$41.4B
$350K 0.01%
+29,571
New +$432K
HSHP
649
Himalaya Shipping
HSHP
$853M
$349K 0.01%
26,156
+11,099
+74% +$160K
BCAX
650
Bicara Therapeutics
BCAX
$1.51B
$349K 0.01%
+11,761
New +$262K
24 25
26
27 28

Similar funds

GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Voleon Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Voleon Capital Management held 957 positions worth $5.49B, up 18% from $4.64B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Voleon Capital Management's Q2 2026 filing shows 177 new, 251 increased, 333 reduced and 196 closed positions. Its largest new stake was AstraZeneca: 125,385 shares worth $23.8M. The largest sale was Astera Labs, an estimated $29.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Voleon Capital Management's largest Q2 2026 buy was AstraZeneca: 125,385 shares worth $23.8M.
  • Voleon Capital Management added most to Microsoft in Q2 2026, an estimated $41.7M increase.
  • Voleon Capital Management's biggest Q2 2026 reduction was Astera Labs, cutting an estimated $29.3M.
  • Voleon Capital Management fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $15.5M.
  • Voleon Capital Management's ten largest holdings make up 29% of its $5.49B portfolio in Q2 2026.
  • Voleon Capital Management opened 177 new positions and closed 196 in Q2 2026.
  • Voleon Capital Management's portfolio value rose 18% quarter-over-quarter to $5.49B.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.